Parties discussed information provided by Newron and changes needed by FDA to consider re-start of enrollment in ENIGMA-TRS 2 ...
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...
Epicrispr Biotechnologies, a clinical-stage company pioneering epigenetic therapies, today announced new interim data from ...
Novel immune reprogramming oral macrocyclic peptides designed for precise modulation of complex biological networks involved in inflammatory, ...
Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia Wayrilz is a BTK inhibitor that works through multi-immune modulation to help ...
Diets rich in sugars and fats are associated with metabolic disorders such as insulin resistance, chronic inflammation and ...
Precise modulation of large-scale brain networks requires neuromodulation technologies capable of delivering frequency-locked stimulation with accurate and stable inter-regional phase control. However ...
Abstract: The transmission of amplitude phase shift keying (APSK) symbols through the spatial modulation (SM) scheme, i.e., the APSK-SM system, possesses the features of both the APSK and SM schemes.
Abstract: We design low-complexity bi-directional (forward and backward) modified Soft-Output Viterbi Algorithm (SOVA) decoders to exploit source memory from binary Markov and hidden Markov model (HMM ...